MarketPeel
Insider Trading Intelligence
Pricing
…
RL

Richard S. Levy

TARA
DIRECTOR · PROTARA THERAPEUTICS, INC. · CIK 0001454983
FILING MIX · LIFETIME50%/50%
BUYS
67
SELLS
67
TOTAL VALUE
$24.12M
COMPANIES
4
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
73,226
AVG SELL PX
$347.43
TRADE KIND
SHOWING 134 / 134
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
38 backtested trades · 8 horizons · 34 pending
Forward-return performance of every backtestable P/S trade by Richard S. Levy, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d38+26.32%+3.53%+0.02%+3.50%+3.82%4.25
14d38+57.89%+2.61%+1.17%+1.44%-4.58%0.79
30d38+63.16%+2.00%+2.48%-0.48%-2.74%-0.35
60d38+100.00%-4.55%+2.95%-7.50%-6.42%-10.58
90d38+71.05%-1.72%+5.89%-7.61%-9.55%-5.66
180d38+89.47%-7.02%+11.56%-18.58%-11.00%-6.87
1y38(14 pending)+54.17%+24.02%+21.86%+2.16%+10.87%—
2y38(20 pending)+55.56%+22.42%+49.54%-27.13%-60.57%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TARA · 31,000 shares · as of Jun 15, 2026
012,75025,50038,25051,000202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 67 buys / 67 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
KOD
KODIAK SCIENCES INC.
PURCHASEGRANT
Stock grant
17,731——17,731Jun 30, 2026Jul 2, 2026 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
454——22,469Jun 17, 2026Jun 18, 2026 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
766——766Jun 17, 2026Jun 18, 2026 ↗View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
31,000——31,000Jun 15, 2026Jun 16, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
12,158——12,158May 29, 2026Jun 2, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
2,799——0May 29, 2026Jun 2, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
2,799——21,956May 29, 2026Jun 2, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
2,026——2,026May 29, 2026Jun 2, 2026 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
782$518.76$405.7K22,095May 22, 2026May 22, 2026 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
40$512.97$20.5K26,097May 22, 2026May 22, 2026 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,497$517.59$774.8K22,877May 22, 2026May 22, 2026 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
343$514.67$176.5K25,754May 22, 2026May 22, 2026 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
151$510.36$77.1K27,186May 22, 2026May 22, 2026 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
657$515.92$339.0K25,097May 22, 2026May 22, 2026 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
40$506.68$20.3K27,657May 22, 2026May 22, 2026 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
320$508.24$162.6K27,337May 22, 2026May 22, 2026 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
80$519.98$41.6K22,015May 22, 2026May 22, 2026 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
723$516.87$373.7K24,374May 22, 2026May 22, 2026 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
439$512.50$225.0K26,137May 22, 2026May 22, 2026 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
610$511.40$312.0K26,576May 22, 2026May 22, 2026 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASE
2,500$7.36$18.4K27,697Feb 23, 2026Feb 24, 2026 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
2,500——0Feb 23, 2026Feb 24, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
683——19,157Feb 1, 2026Feb 4, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
683——0Feb 1, 2026Feb 4, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
683——683Feb 1, 2026Feb 4, 2026 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASE
4,000$16.46$65.8K25,197Jan 26, 2026Jan 26, 2026 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
4,000——0Jan 26, 2026Jan 26, 2026 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
120$526.68$63.2K21,877Nov 13, 2025Nov 14, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
153$524.49$80.2K21,997Nov 13, 2025Nov 14, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
308$520.68$160.4K25,489Nov 13, 2025Nov 14, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
2,500——2,500Nov 13, 2025Nov 14, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,094$521.79$570.8K24,395Nov 13, 2025Nov 14, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
146$514.67$75.1K29,551Nov 13, 2025Nov 14, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,355$519.67$704.1K25,797Nov 13, 2025Nov 14, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
835$518.53$433.0K27,152Nov 13, 2025Nov 14, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
440$528.60$232.6K21,237Nov 13, 2025Nov 14, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASE
6,000$16.46$98.8K29,697Nov 13, 2025Nov 14, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,434$522.70$749.6K22,961Nov 13, 2025Nov 14, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
200$527.85$105.6K21,677Nov 13, 2025Nov 14, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
6,000——4,000Nov 13, 2025Nov 14, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
40$530.21$21.2K21,197Nov 13, 2025Nov 14, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASE
2,500$7.36$18.4K23,697Nov 13, 2025Nov 14, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
811$523.66$424.7K22,150Nov 13, 2025Nov 14, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
645$517.51$333.8K27,987Nov 13, 2025Nov 14, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
919$515.64$473.9K28,632Nov 13, 2025Nov 14, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
1,101——18,474Jul 1, 2025Jul 3, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
1,101——0Jul 1, 2025Jul 3, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
1,101——1,101Jul 1, 2025Jul 3, 2025 ↗View →
KOD
KODIAK SCIENCES INC.
PURCHASEGRANT
Stock grant
40,000——40,000Jun 30, 2025Jul 2, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,290——1,290Jun 20, 2025Jun 24, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
715——21,197Jun 20, 2025Jun 24, 2025 ↗View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
24,000——24,000Jun 12, 2025Jun 13, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
3,173——17,373Jun 5, 2025Jun 5, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
3,173——0Jun 5, 2025Jun 5, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
2,799——2,799Jun 3, 2025Jun 5, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
16,798——16,798Jun 3, 2025Jun 5, 2025 ↗View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASE
20,000$3.19$63.8K51,000May 14, 2025May 16, 2025 ↗View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASE
20,000$3.19$63.8K51,000May 14, 2025May 19, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
9,470——0Apr 10, 2025Apr 11, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASE
9,470$65.06$616.1K20,482Apr 10, 2025Apr 11, 2025 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
5,000——5,000Nov 7, 2024Nov 8, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
5,000$350.00$1.75M11,012Nov 7, 2024Nov 8, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASE
5,000$7.36$36.8K16,012Nov 7, 2024Nov 8, 2024 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
1,303——1,303Nov 7, 2024Nov 12, 2024 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
1,303——0Nov 7, 2024Nov 12, 2024 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
1,303——14,200Nov 7, 2024Nov 12, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
2,800$300.10$840.3K13,212Nov 1, 2024Nov 5, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
5,000——10,000Nov 1, 2024Nov 5, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASE
5,000$7.36$36.8K16,012Nov 1, 2024Nov 5, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,100$301.22$331.3K12,112Nov 1, 2024Nov 5, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
300$304.29$91.3K11,012Nov 1, 2024Nov 5, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
800$302.25$241.8K11,312Nov 1, 2024Nov 5, 2024 ↗View →
KOD
KODIAK SCIENCES INC.
PURCHASEGRANT
Stock grant
40,000——40,000Jun 28, 2024Jul 1, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
714——11,012Jun 25, 2024Jun 27, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,105——1,105Jun 25, 2024Jun 27, 2024 ↗View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,000——10,000Jun 7, 2024Jun 10, 2024 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
4,373——0Jun 6, 2024Jun 7, 2024 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
4,373——12,897Jun 6, 2024Jun 7, 2024 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
3,173——3,173Jun 5, 2024Jun 7, 2024 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
19,040——19,040Jun 5, 2024Jun 7, 2024 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
747——0May 3, 2024May 7, 2024 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
747——747May 3, 2024May 7, 2024 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
747——8,524May 3, 2024May 7, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
100$259.07$25.9K11,311Apr 1, 2024Apr 3, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
300$267.07$80.1K10,298Apr 1, 2024Apr 3, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASE
5,000$7.36$36.8K15,298Apr 1, 2024Apr 3, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
6,000——0Apr 1, 2024Apr 3, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,600$257.93$412.7K11,411Apr 1, 2024Apr 3, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
5,000——15,000Apr 1, 2024Apr 3, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,900$256.88$1.00M13,011Apr 1, 2024Apr 3, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
713$265.28$189.1K10,598Apr 1, 2024Apr 3, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASE
6,000$111.06$666.4K21,298Apr 1, 2024Apr 3, 2024 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
4,387$255.90$1.12M16,911Apr 1, 2024Apr 3, 2024 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
2,777——2,777Nov 3, 2023Nov 7, 2023 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
2,777——7,777Nov 3, 2023Nov 7, 2023 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
2,777——0Nov 3, 2023Nov 7, 2023 ↗View →
KOD
KODIAK SCIENCES INC.
PURCHASEGRANT
Stock grant
40,000——40,000Jun 30, 2023Jul 3, 2023 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
5,000——5,000Jun 29, 2023Jul 3, 2023 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
5,000——0Jun 29, 2023Jul 3, 2023 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,198——10,298Jun 15, 2023Jun 20, 2023 ↗View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,000——10,000Jun 7, 2023Jun 8, 2023 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
4,373——4,373Jun 6, 2023Jun 8, 2023 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
26,236——26,236Jun 6, 2023Jun 8, 2023 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
400$287.08$114.8K31,089Jan 17, 2023Jan 19, 2023 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
5,227$292.68$1.53M20,637Jan 17, 2023Jan 19, 2023 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
3,325$291.66$969.8K25,864Jan 17, 2023Jan 19, 2023 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
5,164$294.68$1.52M11,925Jan 17, 2023Jan 19, 2023 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASE
12,489$105.08$1.31M21,589Jan 17, 2023Jan 19, 2023 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASE
10,000$100.45$1.00M31,589Jan 17, 2023Jan 19, 2023 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
12,489——0Jan 17, 2023Jan 19, 2023 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
2,325$295.45$686.9K9,600Jan 17, 2023Jan 19, 2023 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
1,600$290.36$464.6K29,189Jan 17, 2023Jan 19, 2023 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
300$288.91$86.7K30,789Jan 17, 2023Jan 19, 2023 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
100$285.28$28.5K31,489Jan 17, 2023Jan 19, 2023 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
3,548$293.54$1.04M17,089Jan 17, 2023Jan 19, 2023 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
500$296.68$148.3K9,100Jan 17, 2023Jan 19, 2023 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
SALE
10,000——0Jan 17, 2023Jan 19, 2023 ↗View →
KOD
KODIAK SCIENCES INC.
PURCHASEGRANT
Stock grant
25,000——25,000Jun 30, 2022Jul 5, 2022 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
5,000——5,000Jun 29, 2022Jun 30, 2022 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
30,000——30,000Jun 29, 2022Jun 30, 2022 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
9,470——9,470Jun 16, 2022Jun 17, 2022 ↗View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,000——10,000Jun 8, 2022Jun 9, 2022 ↗View →
KOD
KODIAK SCIENCES INC.
PURCHASEGRANT
Stock grant
7,368——7,368Jun 30, 2021Jul 2, 2021 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
33,237——33,237Jun 29, 2021Jun 30, 2021 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
12,489——12,489Jun 17, 2021Jun 18, 2021 ↗View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,000——10,000Jun 9, 2021Jun 10, 2021 ↗View →
KOD
KODIAK SCIENCES INC.
PURCHASEGRANT
Stock grant
7,106——7,106Jun 30, 2020Jul 2, 2020 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
18,760——18,760Jun 30, 2020Jul 2, 2020 ↗View →
MDGL
MADRIGAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
6,000——6,000Jun 17, 2020Jun 17, 2020 ↗View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,000——9,000Jun 9, 2020Jun 10, 2020 ↗View →
KOD
KODIAK SCIENCES INC.
PURCHASEGRANT
Stock grant
4,135——4,135Jun 8, 2020Jun 10, 2020 ↗View →
KOD
KODIAK SCIENCES INC.
PURCHASE
750$44.65$33.5K1,000Mar 20, 2020Mar 24, 2020 ↗View →
KOD
KODIAK SCIENCES INC.
PURCHASE
250$43.37$10.8K250Mar 20, 2020Mar 24, 2020 ↗View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
31,000——31,000Jan 10, 2020Jan 13, 2020 ↗View →
Other insiders · TARA
Loading peer insiders…
About this filer
CIK 0001454983
ROLE
Director
PRIMARY
TARA
COMPANIES
4
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001454983DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback